Literature DB >> 24472818

SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study.

Elaine Yuen Phin Lee1, Chun Sing Wong, Siu Leung Fung, Pui Kuen Yan, James Chung Man Ho.   

Abstract

OBJECTIVE: We hypothesize that the standardized uptake value (SUV) from PET/computed tomography (CT) can act as an adjunct to forced vital capacity (FVC) in evaluating disease status in idiopathic pulmonary fibrosis (IPF).
METHODS: Eight consecutive male patients diagnosed with IPF were prospectively recruited to undergo full pulmonary function tests, high-resolution computed tomography of the thorax and PET/CT. The corrected mean SUV (rSUVmean) and corrected maximum SUV (rSUVmax) against the mediastinal blood pool were correlated with clinical parameters. Examinations were repeated 6 months later in six patients (2/8 patients had died) and changes were evaluated. Correlation was assessed by Spearman's rank correlation, and statistical significance was considered when the P-value was less than 0.05.
RESULTS: The rSUVmean in IPF was negatively correlated with FVC (r=-0.6, P=0.024) and diffusing capacity for carbon monoxide (r=-0.7, P=0.010). The decline in FVC was associated with an increment in rSUVmax (r=-0.9, P=0.019), but no similar observation was made with total CT score (r=-0.1, P=0.787).
CONCLUSION: Pulmonary metabolism, rSUVmean, contributes to the functional status of IPF patients, and changes in rSUVmax may serve as an adjunct surrogate marker to FVC in evaluating the disease status in IPF patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24472818     DOI: 10.1097/MNM.0000000000000083

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

1.  Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.

Authors:  Paul Flechsig; Olena Hural; Michael Kreuter; Martin Eichhorn; Gudula HEUßEL; Christos Sachpekidis; Hans-Ulrich Kauczor; Uwe Haberkorn; Claus Peter Heussel; Monika Eichinger
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

2.  [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.

Authors:  Aurélien Justet; Astrid Laurent-Bellue; Gabriel Thabut; Arnaud Dieudonné; Marie-Pierre Debray; Raphael Borie; Michel Aubier; Rachida Lebtahi; Bruno Crestani
Journal:  Respir Res       Date:  2017-04-27

3.  The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.

Authors:  Daphne M Peelen; Ben G J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Otto S Hoekstra; Conny J Van der Laken; Alexandre E Voskuyl
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

Review 4.  Experimental and quantitative imaging techniques in interstitial lung disease.

Authors:  Nicholas D Weatherley; James A Eaden; Neil J Stewart; Brian J Bartholmai; Andrew J Swift; Stephen Mark Bianchi; Jim M Wild
Journal:  Thorax       Date:  2019-03-18       Impact factor: 9.139

5.  18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study.

Authors:  Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin
Journal:  Arthritis Res Ther       Date:  2021-03-06       Impact factor: 5.156

6.  18F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery.

Authors:  Hee-Young Yoon; Suk Hyun Lee; Sejin Ha; Jin-Sook Ryu; Jin Woo Song
Journal:  BMC Pulm Med       Date:  2021-09-16       Impact factor: 3.317

7.  The lungs were on fire: a pilot study of 18F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease.

Authors:  Junyu Liang; Heng Cao; Yinuo Liu; Bingjue Ye; Yiduo Sun; Yini Ke; Ye He; Bei Xu; Jin Lin
Journal:  Arthritis Res Ther       Date:  2021-07-23       Impact factor: 5.156

8.  The Value of 18F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients.

Authors:  Hee-Young Yoon; Suk Hyun Lee; Sejin Ha; Jin-Sook Ryu; Jin Woo Song
Journal:  J Korean Med Sci       Date:  2021-10-25       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.